Feb 24, 2026 10:21AM
Jan 5, 2026 04:03PM
Jan 5, 2026 04:03PM
Oct 1, 2025 04:03PM
Jul 24, 2025 12:46PM
Apr 24, 2025 01:49PM
Feb 23, 2023 04:01PM Galapagos announces full year 2022 results and outlook for 2023
Nov 7, 2022 06:23AM
Nov 4, 2022 04:03PM
Nov 4, 2022 04:01PM
Nov 3, 2022 04:01PM
Oct 17, 2022 01:30AM
Aug 4, 2022 04:01PM
May 5, 2022 04:01PM Galapagos demonstrates regulatory and commercial progress in Q1 2022
Mar 15, 2022 06:12AM
Feb 24, 2022 04:01PM
Nov 4, 2021 05:01PM
Aug 6, 2021 01:10PM
Aug 5, 2021 04:01PM
May 6, 2021 04:01PM
Mar 16, 2021 01:30PM Ryvu Therapeutics reports financial results for 2020
Feb 19, 2021 01:02PM
Feb 18, 2021 04:01PM
Feb 10, 2021 09:01AM
Feb 10, 2021 09:00AM
Feb 10, 2021 09:00AM
Dec 15, 2020 04:16PM
Dec 15, 2020 04:15PM Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca® (Filgotinib)
Nov 5, 2020 04:01PM
Sep 15, 2020 01:01PM
Aug 19, 2020 03:28AM
Aug 7, 2020 12:16PM
Aug 6, 2020 04:01PM
Jun 10, 2020 12:58PM
May 7, 2020 04:03PM On track for clinical read-outs and commercial readiness in 2020
Feb 20, 2020 04:01PM
Oct 24, 2019 04:01PM
Aug 23, 2019 04:01PM
Aug 23, 2019 04:01PM
Aug 7, 2019 04:05PM
Jul 25, 2019 04:02PM
Jul 15, 2019 07:29AM S&P ends near flat as Citigroup results sink banks; Nasdaq hits new high
Jul 15, 2019 04:09AM
Jul 15, 2019 04:04AM
Jul 14, 2019 04:13PM
Jul 14, 2019 01:01PM
Jul 14, 2019 01:00PM
Apr 25, 2019 04:02PM
Feb 21, 2019 04:02PM Firmly on our way to becoming a fully integrated biopharma company
Oct 24, 2018 04:04PM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All